Evolus climbs on surprise quarterly profit

Evolus

01/08/2024 15:05

** Shares of cosmetic drugmaker Evolus  EOLS.O  rise 10.8%
to $13.76
    ** EOLS reports Q2 adj. operating income of $1.1 mln vs
analysts' average loss estimate of $1.8 mln
    ** Co's quarterly revenue of $66.9 mln beats analysts'
average expectation of $65.8 mln
        ** EOLS, late on Wednesday, raised its full-year revenue
forecast to a range of $260 mln to $270 mln, up from $255 mln to
$265 mln
    ** Stock up 34.7% YTD
    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))